Dermatofibrosarcoma Protuberans.
Acosta AE, Vélez CS.
Curr Treat Options Oncol. 2017 Aug 10;18(9):56. doi: 10.1007/s11864-017-0498-5.
Chalazion treatment.
Unal M.
Orbit. 2008;27(6):397-8. doi: 10.1080/01676830802623174.
Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.
Wu L, Zhao Z, Shin YJ, Yin Y, Raju A, Vaiyapuri TS, Idzham K, Son M, Lee Y, Sa JK, Chua JYH, Unal B, Zhai Y, Fan W, Huang L, Hu H, Gunaratne J, Nam DH, Jiang T, Tergaonkar V.
Nat Cell Biol. 2024 Jun;26(6):1003-1018. doi: 10.1038/s41556-024-01428-5. Epub 2024 Jun 10.
Ring-Enhancing Lesions-Differentiation with MRI.
Peker E, Ünal S, Uludağ SB, Zorlu NSY.
Br J Hosp Med (Lond). 2024 Oct 30;85(10):1-20. doi: 10.12968/hmed.2024.0195. Epub 2024 Oct 29.
Interventricular septal lipoma.
Açar B, Ünal S, Aladağ P, Ertem AG, Ercan K.
Turk Kardiyol Dern Ars. 2017 Dec;45(8):770. doi: 10.5543/tkda.2017.80195.
A review concerning the breast cancer-related tumour microenvironment.
Rodríguez-Bejarano OH, Parra-López C, Patarroyo MA.
Crit Rev Oncol Hematol. 2024 Jul;199:104389. doi: 10.1016/j.critrevonc.2024.104389. Epub 2024 May 10.
Reactivation of telomerase in cancer.
Akincilar SC, Unal B, Tergaonkar V.
Cell Mol Life Sci. 2016 Apr;73(8):1659-70. doi: 10.1007/s00018-016-2146-9. Epub 2016 Feb 4.
Nivolumab for pediatric malignant peritoneal mesothelioma.
Yaman Ortaköylü M, İncesoy Özdemir S, Dinçaslan H, Taçyıldız N, Ünal AE, Soydal Ç, Fitöz ÖS, Ünal E.
Pediatr Blood Cancer. 2023 Feb;70(2):e29892. doi: 10.1002/pbc.29892. Epub 2022 Jul 19.
Vasogenic Edema Pattern in Brain Metastasis.
Yaltirik Bilgin E, Unal O, Ciledag N.
J Coll Physicians Surg Pak. 2022 Aug;32(8):1020-1025. doi: 10.29271/jcpsp.2022.08.1020.
Venous Invasion in Gastric Cancer.
Ünal E, Karcaaltincaba M.
AJR Am J Roentgenol. 2020 Jan;214(1):W67. doi: 10.2214/AJR.19.21875.
